Cargando…
Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study
OBJECTIVES: To identify the genetic determinants of fracture risk and assess the role of 15 clinical risk factors on osteoporotic fracture risk. DESIGN: Meta-analysis of genome wide association studies (GWAS) and a two-sample mendelian randomisation approach. SETTING: 25 cohorts from Europe, United...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113773/ https://www.ncbi.nlm.nih.gov/pubmed/30158200 http://dx.doi.org/10.1136/bmj.k3225 |
_version_ | 1783351072130072576 |
---|---|
author | Trajanoska, Katerina Morris, John A Oei, Ling Zheng, Hou-Feng Evans, David M Kiel, Douglas P Ohlsson, Claes Richards, J Brent Rivadeneira, Fernando |
author_facet | Trajanoska, Katerina Morris, John A Oei, Ling Zheng, Hou-Feng Evans, David M Kiel, Douglas P Ohlsson, Claes Richards, J Brent Rivadeneira, Fernando |
author_sort | Trajanoska, Katerina |
collection | PubMed |
description | OBJECTIVES: To identify the genetic determinants of fracture risk and assess the role of 15 clinical risk factors on osteoporotic fracture risk. DESIGN: Meta-analysis of genome wide association studies (GWAS) and a two-sample mendelian randomisation approach. SETTING: 25 cohorts from Europe, United States, east Asia, and Australia with genome wide genotyping and fracture data. PARTICIPANTS: A discovery set of 37 857 fracture cases and 227 116 controls; with replication in up to 147 200 fracture cases and 150 085 controls. Fracture cases were defined as individuals (>18 years old) who had fractures at any skeletal site confirmed by medical, radiological, or questionnaire reports. Instrumental variable analyses were performed to estimate effects of 15 selected clinical risk factors for fracture in a two-sample mendelian randomisation framework, using the largest previously published GWAS meta-analysis of each risk factor. RESULTS: Of 15 fracture associated loci identified, all were also associated with bone mineral density and mapped to genes clustering in pathways known to be critical to bone biology (eg, SOST, WNT16, and ESR1) or novel pathways (FAM210A, GRB10, and ETS2). Mendelian randomisation analyses showed a clear effect of bone mineral density on fracture risk. One standard deviation decrease in genetically determined bone mineral density of the femoral neck was associated with a 55% increase in fracture risk (odds ratio 1.55 (95% confidence interval 1.48 to 1.63; P=1.5×10(−68)). Hand grip strength was inversely associated with fracture risk, but this result was not significant after multiple testing correction. The remaining clinical risk factors (including vitamin D levels) showed no evidence for an effect on fracture. CONCLUSIONS: This large scale GWAS meta-analysis for fracture identified 15 genetic determinants of fracture, all of which also influenced bone mineral density. Among the clinical risk factors for fracture assessed, only bone mineral density showed a major causal effect on fracture. Genetic predisposition to lower levels of vitamin D and estimated calcium intake from dairy sources were not associated with fracture risk. |
format | Online Article Text |
id | pubmed-6113773 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61137732018-08-30 Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study Trajanoska, Katerina Morris, John A Oei, Ling Zheng, Hou-Feng Evans, David M Kiel, Douglas P Ohlsson, Claes Richards, J Brent Rivadeneira, Fernando BMJ Research OBJECTIVES: To identify the genetic determinants of fracture risk and assess the role of 15 clinical risk factors on osteoporotic fracture risk. DESIGN: Meta-analysis of genome wide association studies (GWAS) and a two-sample mendelian randomisation approach. SETTING: 25 cohorts from Europe, United States, east Asia, and Australia with genome wide genotyping and fracture data. PARTICIPANTS: A discovery set of 37 857 fracture cases and 227 116 controls; with replication in up to 147 200 fracture cases and 150 085 controls. Fracture cases were defined as individuals (>18 years old) who had fractures at any skeletal site confirmed by medical, radiological, or questionnaire reports. Instrumental variable analyses were performed to estimate effects of 15 selected clinical risk factors for fracture in a two-sample mendelian randomisation framework, using the largest previously published GWAS meta-analysis of each risk factor. RESULTS: Of 15 fracture associated loci identified, all were also associated with bone mineral density and mapped to genes clustering in pathways known to be critical to bone biology (eg, SOST, WNT16, and ESR1) or novel pathways (FAM210A, GRB10, and ETS2). Mendelian randomisation analyses showed a clear effect of bone mineral density on fracture risk. One standard deviation decrease in genetically determined bone mineral density of the femoral neck was associated with a 55% increase in fracture risk (odds ratio 1.55 (95% confidence interval 1.48 to 1.63; P=1.5×10(−68)). Hand grip strength was inversely associated with fracture risk, but this result was not significant after multiple testing correction. The remaining clinical risk factors (including vitamin D levels) showed no evidence for an effect on fracture. CONCLUSIONS: This large scale GWAS meta-analysis for fracture identified 15 genetic determinants of fracture, all of which also influenced bone mineral density. Among the clinical risk factors for fracture assessed, only bone mineral density showed a major causal effect on fracture. Genetic predisposition to lower levels of vitamin D and estimated calcium intake from dairy sources were not associated with fracture risk. BMJ Publishing Group Ltd. 2018-08-29 /pmc/articles/PMC6113773/ /pubmed/30158200 http://dx.doi.org/10.1136/bmj.k3225 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Trajanoska, Katerina Morris, John A Oei, Ling Zheng, Hou-Feng Evans, David M Kiel, Douglas P Ohlsson, Claes Richards, J Brent Rivadeneira, Fernando Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study |
title | Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study |
title_full | Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study |
title_fullStr | Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study |
title_full_unstemmed | Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study |
title_short | Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study |
title_sort | assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113773/ https://www.ncbi.nlm.nih.gov/pubmed/30158200 http://dx.doi.org/10.1136/bmj.k3225 |
work_keys_str_mv | AT trajanoskakaterina assessmentofthegeneticandclinicaldeterminantsoffractureriskgenomewideassociationandmendelianrandomisationstudy AT morrisjohna assessmentofthegeneticandclinicaldeterminantsoffractureriskgenomewideassociationandmendelianrandomisationstudy AT oeiling assessmentofthegeneticandclinicaldeterminantsoffractureriskgenomewideassociationandmendelianrandomisationstudy AT zhenghoufeng assessmentofthegeneticandclinicaldeterminantsoffractureriskgenomewideassociationandmendelianrandomisationstudy AT evansdavidm assessmentofthegeneticandclinicaldeterminantsoffractureriskgenomewideassociationandmendelianrandomisationstudy AT kieldouglasp assessmentofthegeneticandclinicaldeterminantsoffractureriskgenomewideassociationandmendelianrandomisationstudy AT ohlssonclaes assessmentofthegeneticandclinicaldeterminantsoffractureriskgenomewideassociationandmendelianrandomisationstudy AT richardsjbrent assessmentofthegeneticandclinicaldeterminantsoffractureriskgenomewideassociationandmendelianrandomisationstudy AT rivadeneirafernando assessmentofthegeneticandclinicaldeterminantsoffractureriskgenomewideassociationandmendelianrandomisationstudy |